These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 28728209
1. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors. Tomita M, Ayabe T, Tsuchiya K, Nakamura K. Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209 [Abstract] [Full Text] [Related]
3. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M. Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867 [Abstract] [Full Text] [Related]
5. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours. Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, Matsuo K, Yokoi K. Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234 [Abstract] [Full Text] [Related]
6. Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors. Matsumoto I, Oda M, Takizawa M, Waseda R, Nakajima K, Kawano M, Mochizuki T, Ikeda H, Watanabe G. Ann Thorac Surg; 2013 Jan; 95(1):305-10. PubMed ID: 23200236 [Abstract] [Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A. Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658 [Abstract] [Full Text] [Related]
8. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours. Eguchi T, Yoshida K, Hamanaka K, Shiina T, Koizumi T, Kawakami S, Oguchi K, Amano J. Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437 [Abstract] [Full Text] [Related]
9. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F. Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317 [Abstract] [Full Text] [Related]
10. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms? Viti A, Terzi A, Bianchi A, Bertolaccini L. Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467 [Abstract] [Full Text] [Related]
17. Diagnostic and prognostic values of 2-[18F]FDG PET/CT in resectable thymic epithelial tumour. Han S, Kim YI, Oh JS, Seo SY, Park MJ, Lee GD, Choi S, Kim HR, Kim YH, Kim DK, Park SI, Ryu JS. Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035 [Abstract] [Full Text] [Related]